CEPHALEXIN CAPSULES

The Defense Logistics Agency awarded a single-line-item delivery order to DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F7565 for 1.000 bag of CEPHALEXIN CAPSULES with NSN 6505017240531 at a total price of $56.79, with an award date of July 14, 2026. The delivery is scheduled for July 29, 2026, to Fort Bragg, North Carolina, with inspection and acceptance occurring at the destination point under FOB destination terms where the contractor bears all transportation costs and risks. The contract is issued under the basic indefinite-delivery contract SPE2DX25D9900 and reflects a firm-fixed-price arrangement with no variability in quantity, options, or extensions. No special contract requirements, security clearances, key personnel provisions, or organizational conflict of interest clauses are specified, and the procurement appears to follow a Lowest Price Technically Acceptable approach with no stated non-price evaluation factors. The awardee holds CAGE code 1UNB0, and the items sourced likely originate from manufacturers under CAGE codes 1XUY5 and 3V8D7. Shipping must be conducted via the fastest traceable means, excluding parcel post, and must include traceable identification such as the TCN W50YF252590295. Packaging and marking requirements do not reference specific MIL-STD standards, and no formal Section I contract clauses, Section D packaging specifications, Section H special requirements, or Section K representations were included in the available documentation. Payment and invoicing details, including remittance addresses and electronic invoicing platforms, were not provided, and no contracting officer or technical representative information was disclosed. Funding is indicated through DIC A0A, FC Z9, and PR 7017498741, but full accounting codes are not listed. The contract is minimal in scope, lacking detailed technical specifications or quality standards beyond implied compliance with DLA medical supply protocols and military pharmaceutical substitution rankings.